CUC Past Earnings Performance
Past criteria checks 5/6
CUC has been growing earnings at an average annual rate of 18.4%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 23.3% per year. CUC's return on equity is 12.5%, and it has net margins of 9.1%.
Key information
18.4%
Earnings growth rate
7.6%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 23.3% |
| Return on equity | 12.5% |
| Net Margin | 9.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
CUC Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Oct 31
Does CUC (TSE:9158) Have A Healthy Balance Sheet?
Oct 29CUC (TSE:9158) May Have Issues Allocating Its Capital
Sep 04CUC Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 26Is CUC (TSE:9158) Using Too Much Debt?
Jul 17Take Care Before Jumping Onto CUC Inc. (TSE:9158) Even Though It's 27% Cheaper
Jun 15Results: CUC Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 28More Unpleasant Surprises Could Be In Store For CUC Inc.'s (TSE:9158) Shares After Tumbling 35%
Apr 27Revenue & Expenses Breakdown
How CUC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 39,290 | 3,565 | 11,970 | 0 |
| 30 Jun 24 | 35,959 | 3,079 | 13,129 | 0 |
| 31 Mar 24 | 33,025 | 2,595 | 9,833 | 0 |
| 31 Dec 23 | 31,133 | 1,779 | 11,432 | 0 |
| 30 Sep 23 | 31,862 | 1,952 | 10,802 | 0 |
| 30 Jun 23 | 32,737 | 1,992 | 10,459 | 0 |
| 31 Mar 23 | 35,210 | 2,423 | 10,015 | 0 |
| 31 Mar 22 | 35,314 | 2,707 | 8,788 | 0 |
| 31 Mar 21 | 16,606 | 1,100 | 5,711 | 0 |
Quality Earnings: 9158 has high quality earnings.
Growing Profit Margin: 9158's current net profit margins (9.1%) are higher than last year (6.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9158's earnings have grown by 18.4% per year over the past 5 years.
Accelerating Growth: 9158's earnings growth over the past year (82.6%) exceeds its 5-year average (18.4% per year).
Earnings vs Industry: 9158 earnings growth over the past year (82.6%) exceeded the Healthcare industry 8.3%.
Return on Equity
High ROE: 9158's Return on Equity (12.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 23:14 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CUC Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Akinori Ueda | Goldman Sachs |
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Masao Yoshida | Ichiyoshi Research Institute Inc. |